Category: Finance | Title: David Hartman Health: Latest Facts, Companies, and Public Data | Tag: Health Finance | Meta Description: Current facts on David Hartman health, related companies, public records, and key data points in finance and health sectors...
David Hartman Health: Current Public Records and Financial Context
David Hartman health references often intersect with public records, financial disclosures, and company filings. In the latest available public data, individuals named David Hartman appear in SEC filings, corporate registrations, and health sector databases. These records typically include roles in publicly traded companies, investment vehicles, and advisory positions. For example, SEC EDGAR filings list multiple individuals with this name tied to companies in healthcare, technology, and finance. These filings provide structured data on ownership, compensation, and board memberships. The most recent filings show updated roles and affiliations, reflecting ongoing corporate governance changes. SEC EDGAR company search for Hartman provides direct access to these filings.
Health sector involvement for individuals named David Hartman often appears through board seats in medical device firms, health technology startups, and hospital systems. Public data from corporate registries and annual reports confirms positions in companies focused on digital health, telehealth platforms, and medical imaging. These roles typically involve governance, strategic oversight, and capital allocation decisions. Financial disclosures detail compensation structures, equity grants, and transaction approvals. The latest 10-K and 10-Q filings from relevant companies list these directorships with precise dates and terms. Forbes coverage on healthcare board trends contextualizes these governance patterns.
Companies and Financial Data Linked to David Hartman Health
Publicly Traded Entities and Ownership Stakes
Multiple publicly traded companies list David Hartman in executive or director roles within their latest proxy statements and annual reports. These entities span medical technology, health services, and biotechnology subsectors. Ownership data from Form 4 filings and Schedule 13D disclosures tracks equity positions, option exercises, and sales. Recent transactions show share purchases and dispositions aligned with standard 10b5-1 trading plans. Financial figures include exact share counts, transaction prices, and reported values. The data reflects compliance with SEC reporting requirements and exchange rules. SEC EDGAR filings for Hartman-linked companies provide the raw data behind these figures.
Investment Vehicles and Advisory Roles
Beyond public company roles, David Hartman health references include involvement in private equity funds, venture capital vehicles, and advisory boards targeting healthcare and biotech. Limited partnership agreements and fund prospectuses list these affiliations, with capital commitments and management fee structures disclosed in regulatory filings. The latest fund filings show allocations to digital health platforms, diagnostics firms, and therapeutic developers. Performance metrics include internal rate of return benchmarks and capital call schedules. These vehicles often operate under Regulation D exemptions, with accredited investor requirements. Forbes analysis of healthcare venture capital offers context on these investment themes.
Key Facts, Figures, and Data Points on David Hartman Health
Quantitative Metrics from Public Filings
Quantitative data tied to David Hartman health includes exact dollar amounts in compensation tables, equity ownership percentages, and transaction values from SEC filings. Latest 10-K reports